Tag: Horizon Therapeutics
FTC Sues To Stop Amgen’s $27.8 Billion Horizon Therapeutics Buy
The Federal Trade Commission has filed a lawsuit to prevent Amgen's acquisition of Horizon Therapeutics, citing concerns about potential competition limitations in the pharmaceutical...
Amgen To Buy Rival Horizon Therapeutics For $27B
Amgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare, autoimmune diseases, in a deal valued at approximately $26.4 billion.
Each...
